Catalyst Wire Dossier Catalyst Wire Dossier

teclistamab in combination with daratumumab hyaluronidase-fihj

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for teclistamab in combination with daratumumab hyaluronidase-fihj. Get the full timeline:

Most recent: FDA Grants Third Approval Under the National Priority Voucher Program

See pricing